Showing results (721-730 of 875) with videos related to
Sort By:
Pageof 88
Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2021
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease ActivityKlaus Berek, Gabriel Bsteh, Michael Auer, et al.Internet Interventions|February 19, 2019
An Internet based intervention for improving resilience and coping strategies in university students: Study protocol for a randomized controlled trialRocio Herrero, Adriana Mira, Giulia Cormo, et al.Plos One|July 27, 2021
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registryGabriel Bsteh, Hamid Assar, Harald Hegen, et al.European Journal of Neurology|October 20, 2022
Prioritization process for European Academy of Neurology clinical practice guidelinesKatina Aleksovska, Claudio L A Bassetti, Thomas Berger, et al.Journal of Neurology|November 19, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR)Tobias Monschein, Helena Untersteiner, Markus Ponleitner, et al.Neuroimage. Clinical|October 15, 2023
Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic ImagingAlexandra Lipka, Wolfgang Bogner, Assunta Dal-Bianco, et al.Frontiers in Microbiology|March 11, 2021
MARSBOx: Fungal and Bacterial Endurance From a Balloon-Flown Analog Mission in the StratosphereMarta Cortesão, Katharina Siems, Stella Koch, et al.Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2022
Olfactory threshold predicts treatment response in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Klaus Berek, et al.Therapeutic Advances in Chronic Disease|August 11, 2021
Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosisTobias Zrzavy, Esther Daniels, Niklas Stuka, et al.Pageof 88